Insiders · ZVSA

ZVSA insider transactions

ZyVersa Therapeutics Inc. (ZVSA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

ZVSA insiders

Everyone who has filed a Form 3, 4, 5 or 144 at ZyVersa Therapeutics Inc., latest first. Follow anyone to get their next filing.

• Karen A. CashmereChief Commercial Officer, since December 2022
• James SapirsteinDirector, since January 2023
• Pablo A. GuzmanChief Medical Officer, since January 2023
• Robert G FinizioDirector, since December 2022
• Gregory Gene FreitagDirector, since January 2023
• Stephen C. GloverChief Executive Officer, Director, since December 2022
• Peter WolfeChief Financial Officer, since December 2022
• Min-Chul ParkDirector, since December 2022
• INCON Co., Ltd.10% owner
• Katrin RupallaDirector, since January 2023
• Nicholas A. LaBella Jr.Officer, since December 2022
• Daniel J. O'ConnorDirector, 10% owner
• Larkspur Health LLC10% owner, since December 2021
• Raj MehraDirector
• Gregory SkalickyDirector
• Christopher TwittyDirector
• David S. BrionesOfficer, Director
• A.g.p. / Alliance Global Partners Corp.10% owner

Recent Form 3, 4, and 5 filings for ZVSA

• 482d
  SEC Form 4 filed by Chief Commercial Officer Cashmere Karen A.

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 483d
  SEC Form 4 filed by Director Finizio Robert G

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 483d
  SEC Form 4 filed by Chief Executive Officer Glover Stephen C.

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 483d
  SEC Form 4 filed by Chief Medical Officer Guzman Pablo A.

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 483d
  SEC Form 4 filed by Director Freitag Gregory Gene

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 483d
  SEC Form 4 filed by Director Sapirstein James

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 483d
  SEC Form 4 filed by Director Park Min-Chul

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 483d
  SEC Form 4 filed by Chief Financial Officer Wolfe Peter

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 845d
  SEC Form 4 filed by Director Freitag Gregory Gene

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 845d
  SEC Form 4 filed by Director Finizio Robert G

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 845d
  SEC Form 4 filed by Chief Executive Officer Glover Stephen C.

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 845d
  SEC Form 4 filed by Director Park Min-Chul

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 845d
  SEC Form 4 filed by Chief Financial Officer Wolfe Peter

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 845d
  SEC Form 4 filed by Director Sapirstein James

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)
• 845d
  SEC Form 4 filed by Director Cashmere Karen A.

  4 - ZyVersa Therapeutics, Inc. (0001859007) (Issuer)